Company ProfilePremium

Fine Americas Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Fine Americas Inc. - Company showcase

Year Founded & Workforce

1983

10 Employees

Fine Americas Inc. logo

Fine Americas Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Fine Americas Inc. Overview

Fine Americas, Inc. is a specialist supplier of plant growth regulators (PGRs) to the North and South American market. It is not a broad-line crop-protection company. Its focus is the narrow, technically demanding PGR niche, serving two customer sets. The first is greenhouse ornamental growers, who use PGRs to control height, branching and flowering for retail-ready plants. The second is high-value tree-fruit growers (apples, pears, cherries, citrus, grapes), who use PGRs for fruit thinning, sizing, russet control and drop control. Fine works almost entirely with off-patent active ingredients such as paclobutrazol, daminozide, uniconazole, ethephon, chlormequat, 6-benzyladenine, gibberellins and NAA. It competes through proprietary formulation (for example, clear paclobutrazol and high-concentration 6-BA), label expansion, grower-facing technical research and a reputation for quality. Since 2014 it has been part of France's De Sangosse Group. This gives Fine access to a wider biocontrol, crop-nutrition and pest-control portfolio and sister companies in the US, such as Nutrient Technologies.


Company's own description

Fine Americas describes itself on its website and on supplier platforms such as Knowde and the MSU symposium sponsor page in these terms:

  • It develops, manufactures and markets PGRs for agricultural, greenhouse ornamental and landscape markets.

  • It calls itself a center of excellence for PGR technology.

  • It says it serves quality-conscious growers in more than 40 countries.

  • It describes an ongoing investment program in new products, new uses and product value enhancement.

Its current homepage presents the company as a team of dedicated scientists creating PGRs for ornamental and fruit crops. (Source: fine-americas.com, accessed Oct 2026; Knowde store profile; MSU 2025 Fruit Bioregulator Symposium sponsor page.)

Independent characterization

Fine Americas is a formulation-, registration- and market-access business. It is not a discovery-chemistry company. Its value chain works as follows:

  1. Active ingredient sourcing. It buys generic or off-patent technical-grade actives. Trade press has confirmed that its core ornamental products are off-patent chemistries.

  2. Formulation and registration. Fine Agrochemicals Ltd. holds the US EPA FIFRA Section 3 registrations (company number 62097). Fine Americas manages state registrations, such as those in California and New York, through its Walnut Creek regulatory staff.

  3. Technical marketing. It invests heavily in agronomic trial data, university collaborations and grower guides, such as the PGR Guide for Perennials, to create pull-through demand.

  4. Distribution. It sells through horticultural and agricultural distributors rather than directly to most growers. For example, it uses Royal Brinkman Canada for Canadian greenhouse customers.

Revenue model

Revenue streamDescriptionEstimated share
Product sales: ornamental PGRsGreenhouse, nursery and landscape PGR concentrates sold through distributors—
Product sales: fruit / specialty-crop PGRsThinning, sizing, finish and drop-control products for tree fruit, grapes and citrus—
ServicesTechnical advisory, trial support and grower education. These are bundled with product sales and not monetized separately.—
Licensing / subscriptionNone identified—

Customer types and end-markets

  • Commercial greenhouse ornamental growers, including bedding plants, poinsettias, perennials, potted flowering crops and bulbs.

  • Nursery and landscape growers, including woody ornamentals.

  • Tree-fruit growers, including apples, pears and sweet cherries, especially in Washington, Michigan, New York, Pennsylvania, Virginia, Oregon and California.

  • Grape and citrus growers, served through GA3 products.

  • Distributors, who are the immediate customers. Examples include Royal Brinkman Canada and regional ag-retail and horticultural distributors.

Latin America (South America): Leadership statements from 2017 describe growth in the Fine Americas brand in North and South America.

Strategy

There is no annual report or investor day. Strategy is inferred from company statements and observed actions.

Stated strategic themes (paraphrased from company materials):

  1. PGR specialization. Management has emphasized that the company focuses on PGRs alone, and positions this as the basis for its technical leadership.

  2. Continuous investment in new products, new uses (label expansions) and product value enhancement.

  3. Quality through ISO 9001 manufacturing controls maintained across the supply chain.

  4. Americas market expansion across the US, Canada and South America.

  5. Group synergy. In 2017, management framed the combination with Nutrient Technologies as a way to channel De Sangosse nutrition, biostimulant and PGR technologies to North American farmers.

Observed initiatives (last 24 months):

  • ESG commitments, cost programs and medium-term financial targets: Not publicly disclosed.

Products & Services

Pricing for all products is not publicly disclosed. Fine sells through distributors.

Ornamental & Landscape PGRs

ProductActive ingredient / typeFunction and target cropsLaunch / latest versionSource
Dazide (incl. Dazide 85WSG)DaminozideProduces greener, stronger, more compact plants. Widely used on bedding and potted crops and can be tank-mixed with Citadel for synergy.Mid-2000s US launchGreenhouse Canada; Greenhouse Grower
PiccoloPaclobutrazolHeight controlMid-2000sGreenhouse Grower
Piccolo 10XCPaclobutrazol, higher concentrationHeight control. Marketed as a clear paclobutrazol solution.Late 2000s–2010sGreenhouse Canada; PerishableNews
ConciseUniconazoleDenser plants with longer shelf lifeMid-2000s; state registrations rolled out progressivelyGreenhouse Grower; Greenhouse Canada
CollateEthephon (concentrated)Increases lateral branching, delays flowering and inhibits internode elongation. Also controls height and stem topple in daffodil and hyacinth. Valued for reducing labor (mechanical pinching).Undated US introductionGreenhouse Grower; Greenhouse Management
Configure2% 6-benzyladenine (N-(phenylmethyl)-1H-purine-6-amine)Branching and flowering in Christmas cactus, hosta (including propagation offsets) and echinacea. Ready-to-mix spray.Described as the first registered 2% formulation of this AIGreenhouse Grower
Citadel11.8% chlormequat chlorideHeight control in poinsettias, geraniums, azaleas, hibiscus and bedding plants. Produces darker foliage, thicker leaves and stronger stems for shipping.UndatedGreenhouse Grower
FrescoCytokinin/gibberellin PGRRevitalizes over-regulated or stalled crops such as lilies and poinsettias. Supports healthier foliage and bract quality. For indoor or outdoor use.Core line since mid-2000s; featured Jan 2026GrowerTalks; Greenhouse Grower
FlorgibGibberellic acid (GA3)Ornamental gibberellin applicationsMid-2000sGreenhouse Grower

Fruit & Specialty Crop PGRs

ProductActive ingredientFunction and target cropsEPA Reg. / latest labelSource
Exilis6-BAPost-bloom apple thinning and fruit weight. Early registration covered MI, NY, OR, PA and VA.62097-8 (2000)US EPA
Exilis Plus6-BAPost-bloom apple thinning and sizing. Marketed as having the highest % of 6-BA labeled for apples and pears.62097-9 (2005 label)US EPA; Growing Produce
Exilis 5 XL (ABN Exilis 9.5 SC)6-BAPost-bloom thinning in apples and pears. Can increase branching and feathering in apple, pear and non-bearing cherry nursery trees.62097-33; amended Apr 2023 and Jul 2024US EPA
Novagib 10LGA4 (+GA7 per label class)Reduces climatic russeting in apples, controls Stayman cracking and sizes sweet cherries (added 2016). OMRI-listed.62097-7; amended 2010 and 2016US EPA; Growing Produce
Novagib 5LGA4Apple russet reduction (lower concentration)62097-47; amended Aug 2022US EPA
PerlanGA4 + 6-BAImproves typiness (shape) and size of applesUndatedGrowing Produce
RefineNaphthaleneacetic acid (NAA)Thinning, pre-harvest drop control and return bloom in apples and pears. Also labeled for citrus and olives.Section 3 registration Mar 2015Fruit Growers News
FalgroGA3Quality and yield in grapes, citrus and cherriesUndatedGrowing Produce
Blush—Fruit PGR (named in product list)—Fruit Growers News
Kudos—Fruit PGR (named in product list)—Fruit Growers News
Motivate—Fruit PGR (named in product list)—Fruit Growers News

Services

ServiceDescription
Technical servicesA field technical services team supports growers with trials and rate guidance. Named managers over time include Kevin Forney and Jim Scruggs.
Regulatory servicesA technical and regulatory services coordinator role was created to support label expansion and testing.
Grower educationThe PGR Guide for Perennials (2020–21 edition) is a crop-by-crop rate table. It was developed with researchers at Virginia Tech (Latimer) and NC State (Whipker).
Third-party comparison testingFine has historically provided comparison data against competing PGRs, while encouraging growers to run their own trials.

Financial Narrative

Fine Americas is a private subsidiary and publishes no financial statements. It is consolidated within De Sangosse, which does not publish consolidated accounts at a subsidiary level. Every audited line item below is therefore not publicly disclosed (NA). The only available revenue datapoint is a third-party aggregator estimate of about USD 30M (RocketReach, 2026). It is unaudited and cannot be verified, so it is excluded from the chartable tables.

Margins

Revenue CAGR (FY2021–FY2025): not publicly disclosed.

Parent-level reference data (De Sangosse; not Fine Americas)

These figures are shown only for context on the parent's scale. They are not Fine Americas figures, and the sources conflict.

Source: Businesscoot, from French registry filings (FYE 31 Aug). Le Journal des Entreprises separately shows a later statutory turnover of about EUR 140.4M with net profit of about EUR 19.9M, but the year is not clearly labeled.

Commentary

No trend analysis based on filings is possible. Indirect indicators of commercial trajectory are:

  • Continued investment in label maintenance and expansion, with EPA amendments in 2022, 2023 and 2024.

  • Platinum-tier sponsorship of an international fruit bioregulator symposium in 2025.

  • Ongoing product promotion in 2026.

Together, these point to a stable, actively managed franchise rather than a run-off business. The roughly 10-person headcount estimate suggests a lean commercial, technical and regulatory hub. Manufacturing and formulation are likely carried out by group facilities or toll manufacturers (not publicly disclosed). Revenue per employee implied by the aggregator estimate would be about USD 3M.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

De Facto Segment Details

De facto segmentContentsKey products

Ornamental & Landscape PGRs

Greenhouse, nursery and landscape height control, branching and flowering

Piccolo, Piccolo 10XC, Dazide, Concise, Collate, Configure, Citadel, Fresco, Florgib

Fruit & Specialty Crop PGRs

Fruit thinning, sizing, russet control, fruit finish, drop control and return bloom

Exilis Plus, Exilis 5 XL, Novagib 10L/5L, Perlan, Refine, Falgro, Blush, Kudos, Motivate

Income Statement

MetricFY2015FY2016FY2017FY2018FY2019

De Sangosse SAS statutory turnover (EUR Mn)

199.5118.0101.296.485.4

De Sangosse SAS statutory net profit (EUR Mn)

15.915.57.16.56.7

Capital Markets

ItemStatus

Share price performance (1/3/5-year)

Not applicable (private)

P/E, EV/EBITDA, EV/Sales, P/B

Not applicable (private)

Analyst consensus

None. There is no analyst coverage.

Dividend history / policy

Not publicly disclosed (intra-group)

Credit ratings (Moody's / S&P / Fitch)

Not rated

Parent credit indicator

A French registry aggregator assesses De Sangosse SAS's default risk as very low and says the majority shareholder has strong financial capacity (Le Journal des Entreprises; unaudited third-party score)

Metric

FY2021

Analyst Conclusions

Management guidance: None published.

Consensus expectations: None. There is no coverage.

Bull case

  1. Volume tailwind from fruit. A larger US apple crop (about 279M bushels forecast for 2025–26 versus about 260M) and the expansion of cherry sizing and nursery-feathering labels should lift demand for Exilis and Novagib.

  2. Labor economics favor PGRs. Documented grower adoption of Collate + Dazide to replace hand pinching links demand to structural labor-cost inflation.

  3. Parent synergies. De Sangosse's nutrition, biostimulant and biocontrol lines could be cross-sold through Fine's grower relationships, as management framed in 2017.

Bear case

  1. Commoditization. Off-patent actives leave Fine exposed to low-cost generics, with only formulation and service as defenses.

  2. Regulatory attrition. Registration review of legacy actives could narrow labels or remove products, and a small regulatory team must defend many registrations.

  3. Scale limits. A roughly 10-person organization competes against multinational suppliers with far larger field forces and R&D budgets.

Key catalysts and monitorables (next 12 months)

  • New EPA label amendments or Section 3 registrations under company number 62097.

  • Leadership announcements at Fine Americas or Nutrient Technologies, including confirmation of current presidency.

  • Any De Sangosse reorganization of North American subsidiaries.

  • The 2027 spring fruit-thinning season and the US apple crop forecast.

  • New ornamental product introductions in GrowerTalks and Greenhouse Grower.

  • EPA registration review decisions on paclobutrazol, daminozide, chlormequat and ethephon.

Analyst verdict

Fine Americas, Inc. is not a public company, and any workflow that treats it as one should be corrected. It is a small, privately held, wholly owned US subsidiary of the UK-based Fine Holdings group, which France's family-controlled De Sangosse Group has owned since July 2014. It has no listed securities, no SEC disclosure and no audited standalone financials in the public domain. The only revenue indicator, an aggregator estimate of about USD 30M, should be treated as indicative at best.

Operationally, the business is coherent and durable. Fine has built a credible niche franchise in plant growth regulators across two complementary markets: greenhouse ornamentals and high-value tree fruit. Its moat does not come from molecule patents, since its core actives are off-patent. It comes from four accumulated assets:

  • a portfolio of maintained federal and state registrations;

  • distinctive formulations;

  • a reputation for technical service built over decades with universities and growers;

  • trademarks that are well known in their niche, such as Piccolo, Dazide, Exilis and Novagib.

Continued EPA label activity through 2024 and visible market investment in 2025–26 indicate that the parent continues to fund the franchise.

The main risks are structural: generic price pressure, regulatory review of legacy chemistries, and the fragility of a very lean organization. The main opportunities are labor-driven adoption in greenhouses, a recovering US apple crop, and cross-selling within the De Sangosse group.

For counterparty, supplier or competitive-intelligence purposes, Fine Americas should be assessed as a stable specialist backed by a solid parent, not as an investable security. Any credit or commercial exposure should be underwritten at the De Sangosse group level, with direct confirmation of current leadership and financials requested from the company.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitle (as last reported)Tenure / contextPrior roles / educationSource

Greg Johnson

President, Fine Americas; also led Nutrient Technologies from Dec 2017

Joined Fine in 2004 and promoted from VP Sales & Marketing to President

Arysta LifeScience (Director of Global Marketing; Director of Business Operations Western Hemisphere); AgriDyne Technologies; CIBA-GEIGY

Fruit Growers News; Nursery Management; Greenhouse Grower

Julian Ward

Managing Director, Fine Holdings Group (UK)

Reported in 2017

—

Fruit Growers News

Nicolas Fillon

CEO / Président, De Sangosse Group

Reported in 2017 and in registry data

—

Fruit Growers News; Businesscoot

Christophe Maquin

President of the Supervisory Board, De Sangosse

Current registry listing

—

Le Journal des Entreprises

Jim Scruggs

Technical Services Manager

Reported in 2010s

—

Greenhouse Management; Fruit Growers News

Kevin Forney

Technical Services / Technical Manager

Earlier period

—

Greenhouse Grower

Andrew (Drew) Hubbard

Technical & Regulatory Services Coordinator

Undated hire

BS in Production Horticulture (University of Illinois); MS in Plant Pathology (Oregon State); previously at G.S. Long Co., Yakima

Greenhouse Management

Jolanta Ozatalay

Regulatory Manager

EPA correspondence 2022–2024

—

US EPA

Donette Faulk

Sales Manager

Undated appointment

—

Greenhouse Grower

Dan Skoczylas

Director of Business Development, North America

Current per aggregator

—

RocketReach

“—” = not publicly disclosed.

Major Shareholders

HolderStakeNote

De Sangosse Group (via Fine Holdings Ltd)

100% (wholly owned subsidiary)

Fine Americas is described as wholly owned by Fine Holdings Ltd; the group was acquired by De Sangosse in July 2014

Competitive Landscape

Key Competitors

CompetitorSegment overlapPositioning vs. Fine

Valent BioSciences (Sumitomo Chemical)

Fruit and ornamental PGRs (gibberellins, 6-BA/GA combinations, ACC-based thinners, ReTain AVG)

Market leader in biorational PGRs with a much larger scale and R&D base

Fine Holdings' generic-PGR peers: Nufarm

Ornamental and fruit PGRs (generic ethephon, gibberellins)

Broader generic portfolio and larger distribution reach

OHP, Inc.

Greenhouse ornamental PGRs (e.g., paclobutrazol, uniconazole products)

Direct ornamental competitor focused on greenhouse and nursery

SePRO Corporation

Ornamental PGRs (e.g., paclobutrazol, flurprimidol) and landscape/turf growth regulators

Strong in greenhouse and landscape

Bayer Crop Science

Ethephon and other PGRs (ag and fruit)

Large-cap, broad portfolio

BASF

Prohexadione-calcium (Apogee/Kudos-class) for fruit; mepiquat in row crops

Major in fruit vegetative growth control

AMVAC (American Vanguard)

Ag PGRs and NAA-type products

Mid-cap US ag-chem

Corteva Agriscience

Fruit and ag chemicals (adjacent)

Broad portfolio, indirect competitor

Arysta LifeScience legacy (now UPL)

Ethephon and fruit PGRs

Large generic player

Fine Americas' generic AI resellers (various)

Paclobutrazol, daminozide, ethephon generics

Price-based competition on off-patent actives

Peer Comparison FY2019

MetricFine AmericasValent BioSciencesNufarm (group)SePRO

Revenue

Not publicly disclosed (about USD 30M aggregator estimate)

Not separately disclosed (inside Sumitomo)

—

Not publicly disclosed (private)

PGR focus

PGR pure-play

Biorationals and PGRs

Diversified crop protection

Aquatics, ornamentals, turf

Recent Developments

*Earlier, still-relevant regulatory items: an EPA label revision for Exilis 5 XL (receipt Mar 2024, approved Jul 2024) and an Apr 2023 amendment.

*Not identified in public sources: leadership changes, guidance revisions, litigation, layoffs, restructurings or contract wins in the 18-month window.

Company Snapshot

10

Employees

1983

Founded

USA. Sources show both Suite, US

Headquarters

SWOT Analysis

Strengths

  • PGR pure-play expertise. Management positions its focus on PGRs alone as core to its technical leadership (PerishableNews, Feb 2020).
  • Broad registered portfolio. There are at least 9 ornamental and 11 fruit products, with EPA company number 62097 covering multiple registrations (US EPA PPLS).
  • Differentiated formulations. Exilis Plus is marketed as having the highest 6-BA content labeled for apples and pears, and Piccolo XC as a clear paclobutrazol solution (Growing Produce; Greenhouse Canada).
  • Active label maintenance. EPA label amendments were approved in Aug 2022, Apr 2023 and Jul 2024 (US EPA).
  • Customer loyalty. A Maryland grower that has used Fine products since the 1980s says it uses essentially the full line (Greenhouse Management).
  • Strategic parent. De Sangosse has owned the business since July 2014 and also owns the sister company Nutrient Technologies (Knowde; Fruit Growers News).
  • Quality credentials. The group has held ISO 9001 accreditation since 1992 (Greenhouse Grower).

Weaknesses

  • Off-patent actives. Core ornamental products use off-patent chemistries, so there is no patent moat (Greenhouse Grower).
  • Small scale. The headcount is about 10 (RocketReach), which limits field coverage.
  • No public financial transparency. This complicates counterparty and credit assessment.
  • Slow state registration rollouts in the past. For example, Concise was delayed in New York and California (Greenhouse Grower).
  • Distributor dependence. This limits pricing power and grower data visibility (Greenhouse Canada).
  • Key-person concentration. One executive (Johnson) led both Fine Americas and Nutrient Technologies from 2017 (Fruit Growers News).

Opportunities

  • Larger US apple crops. The 2025–26 forecast is about 279M bushels versus about 260M in 2024–25, which raises thinning demand (USApple).
  • Cherry sizing. This expansion was added to the Novagib 10L label in 2016 (US EPA).
  • Nursery-tree feathering. This claim appears on the Exilis 5 XL label (US EPA).
  • Organic production growth for OMRI-listed Novagib (Growing Produce).
  • Bundling with De Sangosse biocontrol and nutrition offerings in North America (Fruit Growers News, 2017).
  • South America expansion, cited by management as a growth area (Greenhouse Grower).

Threats

  • Generic competition on paclobutrazol, ethephon and daminozide.
  • Regulatory re-evaluation of legacy actives under FIFRA registration review. Every label carries cancellation conditions for non-compliance (US EPA letters).
  • Large competitors with broader portfolios and larger R&D budgets, such as Valent BioSciences and BASF.
  • Weather volatility affecting the thinning and russet seasons. Novagib efficacy is reduced by rain within 6 hours of application (US EPA label).
  • Floriculture demand cyclicality and grower consolidation.
  • Tariff and supply-chain risk on imported technical actives (inferred industry risk; not specifically disclosed).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Jun 23–26, 2025Platinum sponsor of the XV ISHS International Symposium on Plant Bioregulators in Fruit Production, ChicagoSignals continued commitment to the tree-fruit PGR franchise and to scientific credibility
2025 (undated)Greenhouse Management feature on a grower (Catoctin Mountain Growers, MD) using Collate + Dazide for labor savingsThird-party customer validation of the ornamental line's labor-reduction value
Jan 2026Fresco featured in GrowerTalks "Trending Now" (25,000+ subscriber trade publication)Active promotion of the ornamental portfolio into the 2026 season
2026Aggregator data list about 10 employees and about USD 30M estimated revenueIndicates a lean commercial structure

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Income Statement: De Sangosse SAS statutory turnover fell from EUR 199.5 Mn in FY2015 to EUR 85.4 Mn in FY2019.
Fine Americas Inc. — Income Statement
Series (EUR Mn)FY2015FY2016FY2017FY2018FY2019
De Sangosse SAS statutory turnover199.5118101.296.485.4
De Sangosse SAS statutory net profit15.915.57.16.56.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.